Jaguar Health (JAGX) Gross Margin (2015 - 2026)

Jaguar Health (JAGX) has 12 years of Gross Margin data on file, last reported at 94.29% in Q1 2026.

• Gross Margin for Q1 2026 came in at 94.29%, up 1755.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 55.08% (down 3603.0% YoY), and the FY2025 annual result was 19.77%, down 6350.0% from the prior year.
• Gross Margin advanced to 94.29% in Q1 2026 per JAGX's latest filing, from 136.82% in the prior quarter.
• Over five years, Gross Margin peaked at 15943.75% in Q4 2022 and troughed at 4086.67% in Q1 2023.
• A 5-year average of 613.16% and a median of 43.99% in 2024 frame the typical range for Gross Margin.
• The sharpest annual moves came in 2022 and 2023: Gross Margin surged 1586572 bps in 2022, then slumped 1587362 bps in 2023.
• A 5-year view of Gross Margin shows it stood at 15943.75% in 2022, then sank by 100 bps to 70.13% in 2023, then surged by 165 bps to 186.12% in 2024, then tumbled by 174 bps to 136.82% in 2025, then jumped by 169 bps to 94.29% in 2026.
• Business Quant data shows JAGX's Gross Margin at 94.29% in Q1 2026, 136.82% in Q4 2025, and 35.23% in Q3 2025.